课题基金 / 基金详情

NSF/FDA SIR: Isolation of cancer stem cells and the determination of the role of microRNA in B cell differentiation by flow cytometric techniques

NSF/FDA SIR: Isolation of cancer stem cells and the determination of the role of microRNA in B cell differentiation by flow cytometric techniques
NSF/FDA SIR:通过流式细胞技术分离癌症干细胞并确定 microRNA 在 B 细胞分化中的作用
批准号:
1343519
负责人:
Elizabeth Raveche
金额:
$11.45万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2014-08-31

项目摘要

项目成果

Elizabeth Raveche的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract#1343519Raveche, ElizabethThis proposal employs multiparameter analysis of individual cells using markers with specific fluorescence tags that upon laser excitation emit a signal that can be distinguished from all other signals and background. Through this multi-color analysis exquisitely small samples can be identified and ultimately sorted and employed in molecular and functional assays. . This proposed research will test the ability of this technology to define unique malignant precursor cells that will be important for future scientific breakthroughs. This proposal initially takes advantage of the engineering advancements that have allowed fluorescent dyes with unique excitation and emission profiles to result in the ability to differentially excite and collect these emissions. The analysis of individual cells (or particles) rather than the whole population allows for detection of multiple properties measured on the same cell. The detection is rapid (as fast as the cell in the fluid sheath passes through the laser beam). In addition to analysis of individual cells, some types of flow cytometers can physically sort cells based on signals associated with the parameters being detected. and scientific research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSF/FDA SIR: Isolation of Cancer Stem Cells by Flow Cytometric Techniques
国内基金
海外基金
FDA上市药物库筛选鉴定靶向治疗ARID1A缺陷型结直肠癌的合成致死效应及分子机制研究
  • 批准号:
    82373165
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    李爱民
  • 依托单位:
多维互质结构FDA雷达稀疏空时距自适应处理研究
  • 批准号:
    61771317
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2017
  • 负责人:
    阳召成
  • 依托单位:
基于FDA标记畸胎瘤细胞联合人胎盘屏障体外模型建立中药胚胎毒性评价体系的研究
  • 批准号:
    81573740
  • 项目类别:
    面上项目
  • 资助金额:
    63.0万元
  • 批准年份:
    2015
  • 负责人:
    宋殿荣
  • 依托单位: